Back
CytoMed Therapeutics Ltd. 10K Form
Sell
29
GDTC
CytoMed Therapeutics Ltd.
Last Price:
$1.88
Seasonality Move:
-6.92%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GDTC News And Ratings
See the #1 stock for the next 7 days that we like better than GDTC
GDTC Financial Statistics
Sales & Book Value
| Annual Sales: | $52K |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.65 |
| Price / Book: | 3.1 |
Profitability
| EPS (TTM): | -0.19340 |
|---|---|
| Net Income (TTM): | $-2.3M |
| Gross Margin: | $-515.8K |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
CytoMed Therapeutics Ltd. Earnings Forecast
Key CytoMed Therapeutics Ltd. Financial Ratios
-
The Gross Profit Margin over the past 5 years for GDTC is -991.92%.
-
The Selling, General & Administrative Expenses for GDTC have been equal to 690.38% of Gross Profit Margin.
-
The Research & Development expenses have been 2,747.69% of Revenue.
-
The Net Earning history of GDTC is -3,628.85% of Total Revenues.
-
Per Share Earnings over the last 5 years have been positive in 2 years.
CytoMed Therapeutics Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GDTC |
| Website: | cytomed.sg |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
GDTC Technical Analysis vs Fundamental Analysis
Sell
29
CytoMed Therapeutics Ltd. (GDTC)
is a Sell
Is CytoMed Therapeutics Ltd. a Buy or a Sell?
-
CytoMed Therapeutics Ltd. stock is rated a SellThe current CytoMed Therapeutics Ltd. [GDTC] share price is $1.77. The Score for GDTC is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.